🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This exploratory double blind randomized active controlled study is designe...
Status
Terminated
Location
GWT-TUD GmbH / Studienzentrum Hanefeld
Start Date
2015-09
Trial ID
NCT02373865
Treatments Being Tested
This study is a phase 3b, multicentre, randomised, open label, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2001-04
Trial ID
NCT00379769
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01357252
Treatments Being Tested
The purpose of the trial is to verify the effectiveness and safety of glime...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2022-01-01
Trial ID
NCT05386186
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of once-week...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-01
Trial ID
NCT01769378
Treatments Being Tested
This trial is conducted in Europe and Oceania. The aim of this trial is to ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-08
Trial ID
NCT01511172
Treatments Being Tested
We designed this prospective, randomized control study to compare the benef...
Status
Completed
Location
Division of Endocrinology and Metabolism, Department of Medicine
Start Date
2005-10
Trial ID
NCT00506194
This study will evaluate whether the addition of Sitagliptin treatment prov...
Status
Completed
Location
Multiple Locations
Start Date
2010-06-03
Trial ID
NCT01076075
Diabetes is an independent risk factor for ischemic heart disease (CAD) and...
Status
Completed
Location
Universital Hospital Mater Domini
Start Date
2016-04
Trial ID
NCT04183868
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of Sotagliflozin 400...
Status
Completed
Location
Investigational Site Number 8407040
Start Date
2017-12-01
Trial ID
NCT03332771
Treatments Being Tested